Cargando…

In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia

Unfortunately, the options for treating multidrug-resistant (MDR) Acinetobacter baumannii (A. baumannii) infections are extremely limited. Recently, fosfomycin and minocycline were newly introduced as a treatment option for MDR A. baumannii infection. Therefore, we investigated the efficacy of the c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ku, Nam Su, Lee, Su-Hyung, Lim, Young- soun, Choi, Heun, Ahn, Jin Young, Jeong, Su Jin, Shin, Sung Jae, Choi, Jun Yong, Choi, Young Hwa, Yeom, Joon-Sup, Yong, Dongeun, Song, Young Goo, Kim, June Myung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868184/ https://www.ncbi.nlm.nih.gov/pubmed/31748527 http://dx.doi.org/10.1038/s41598-019-53714-0

Ejemplares similares

A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii in Korea
por: Son, Young Woong, et al.
Publicado: (2017)

Inhaled Colistin for Treatment of Pneumonia due to Colistin-Only-Susceptible Acinetobacter baumannii
por: Choi, Hee Kyoung, et al.
Publicado: (2014)

Differences in Colistin-resistant Acinetobacter baumannii Clinical Isolates Between Patients With and Without Prior Colistin Treatment
por: Park, Yu Jin, et al.
Publicado: (2018)

Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients
por: Kim, Won-Young, et al.
Publicado: (2016)

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017)

In vitro antibacterial activity of combinations of fosfomycin, minocycline and polymyxin B on pan-drug-resistant Acinetobacter baumannii
por: ZHANG, YAJUN, et al.
Publicado: (2013)

Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii
por: Leelasupasri, Sombat, et al.
Publicado: (2018)

In Vitro Synergistic Activity of Biapenem Combination with Sulbactam, Colistin, and Fosfomycin Sodium Against Multidrug-resistant Acinetobacter baumannii Isolates from Tertiarycare Hospitals in Thailand
por: Houngsaitong, Jantana, et al.
Publicado: (2017)

In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii
por: Park, Gyun Cheol, et al.
Publicado: (2016)

Colistin plus Sulbactam or Fosfomycin against Carbapenem-Resistant Acinetobacter baumannii: Improved Efficacy or Decreased Risk of Nephrotoxicity?
por: Saelim, Weerayuth, et al.
Publicado: (2021)

489. Risk Factors for Mortality in Patients with Elizabethkingia and Clinical Impact of Antimicrobial Susceptibility Patterns
por: Seong, Hye, et al.
Publicado: (2019)

The Outcomes of Using Colistin for Treating Multidrug Resistant Acinetobacter Species Bloodstream Infections
por: Lim, Seung-Kwan, et al.
Publicado: (2011)

407. Changes in the Utilization Patterns of Antifungal Agents, Medical cost, and Clinical Outcomes of Candidemia by Healthcare Benefit Expansion to Include Newer Antifungal Agents
por: Choi, Heun, et al.
Publicado: (2018)

Combination therapy with polymyxin B and netropsin against clinical isolates of multidrug-resistant Acinetobacter baumannii
por: Chung, Joon-hui, et al.
Publicado: (2016)

2584. Effects of Fecal Microbiota Transplantation for Decolonizing Multidrug-Resistant Organism
por: Seong, Hye, et al.
Publicado: (2019)

In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii
por: Bae, Seongman, et al.
Publicado: (2016)

Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates
por: Kon, Hadas, et al.
Publicado: (2021)

Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii
por: Nordqvist, H., et al.
Publicado: (2016)

Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination
por: Sato, Yoshinori, et al.
Publicado: (2021)

Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone–resistant strains
por: Kim, Eun Jin, et al.
Publicado: (2019)

1366. Prognostic Factors for Unfavorable Outcomes of Patients with Spinal Tuberculosis in a Country with an Intermediate Tuberculosis Burden: a Multi-Center Cohort Study
por: Ho Kim, Jung, et al.
Publicado: (2019)

Absence of neutralizing activity in serum 1 year after successful treatment with antivirals and recovery from MERS in South Korea
por: Choi, Jun Yong, et al.
Publicado: (2019)

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)

In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii
por: Ju, Yong Guk, et al.
Publicado: (2022)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Evaluation of the synergistic effect of a combination of colistin and tigecycline against multidrug-resistant Acinetobacter baumannii
por: Kaya, Ilkem Acar, et al.
Publicado: (2017)

Colistin potentiation in multidrug-resistant Acinetobacter baumannii by a non-cytotoxic guanidine derivative of silver
por: Kumar, Deepak, et al.
Publicado: (2023)

Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients
por: Liang, Wang, et al.
Publicado: (2011)

Using comparative genomics to understand molecular features of carbapenem-resistant Acinetobacter baumannii from South Korea causing invasive infections and their clinical implications
por: Kim, Min Hyung, et al.
Publicado: (2020)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Impact of matrix-assisted laser desorption/ionization time of flight mass spectrometric evaluation on the clinical outcomes of patients with bacteremia and fungemia in clinical settings lacking an antimicrobial stewardship program: a pre-post quasi experimental study
por: Jeon, Yong Duk, et al.
Publicado: (2018)

Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection
por: Chen, Zhijin, et al.
Publicado: (2015)

Curcumin alleviates persistence of Acinetobacter baumannii against colistin
por: Kaur, Amanjot, et al.
Publicado: (2018)

Two types of colistin heteroresistance in Acinetobacter baumannii isolates
por: Hong, Yoon-Kyoung, et al.
Publicado: (2020)

New Mutations Involved in Colistin Resistance in Acinetobacter baumannii
por: Sun, Bingbing, et al.
Publicado: (2020)

Colistin Treatment Affects Lipid Composition of Acinetobacter baumannii
por: Tao, Ye, et al.
Publicado: (2021)

Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology
por: Novović, Katarina, et al.
Publicado: (2023)

PYED-1 Overcomes Colistin Resistance in Acinetobacter baumannii
por: Stabile, Maria, et al.
Publicado: (2023)

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d0pvgf08jjs2lung1s0g0iof8l